Effects of oral adsorbent AST-120 (Kremezin(R)) on progression of chronic renal failure (CRF); A randomized controlled study.

被引：0
|
作者：
Owada, A
Shiigai, T
Nakao, M
机构：
[1] TORIDE KYODO GEN HOSP,DEPT INTERNAL MED,IBARAKI,OSAKA,JAPAN
[2] KUREHA CHEM IND CO LTD,TOKYO,JAPAN
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1996年 / 7卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A0753 / A0753
页数：1
相关论文
共 50 条
  • [41] The influence of oral carbon adsorbent, AST-120, on the production of soluble Flt-1 and the progression of atherosclerosis
    Nakada, Yasuki
    Onoue, Kenji
    Kumazawa, Takuya
    Ishihara, Satomi
    Nakano, Tomoya
    Nakagawa, Hitoshi
    Saito, Yoshihiko
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2020, 140 : 41 - 41
  • [42] Oral charcoal adsorbent (AST-120) prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stress
    Fujii, Hideki
    Nishijima, Fuyuhiko
    Goto, Sumie
    Sugano, Mikio
    Yamato, Hideyuki
    Kitazawa, Riko
    Kitazawa, Sohei
    Fukagawa, Masafumi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (07) : 2089 - 2095
  • [43] The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials
    Schulman, Gerald
    Berl, Tomas
    Beck, Gerald J.
    Remuzzi, Giuseppe
    Ritz, Eberhard
    Shimizu, Miho
    Shobu, Yuko
    Kikuchi, Mami
    BMC NEPHROLOGY, 2016, 17 : 1 - 8
  • [44] Effect of oral adsorbent AST-120 on plasma metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 concentrations in chronic renal failure
    Ebihara, I
    Nakamura, T
    Ushiyama, C
    Suzuki, S
    Shimada, N
    Koide, H
    NEPHRON, 1999, 83 (02): : 169 - 169
  • [45] Oral adsorbent AST-120 ameliorates endothelial dysfunction independent of renal function in rats with subtotal nephrectomy
    Tamehachi Namikoshi
    Naruya Tomita
    Minoru Satoh
    Takeo Sakuta
    Atsunori Kuwabara
    Shinya Kobayashi
    Yuusuke Higuchi
    Fuyuhiko Nishijima
    Naoki Kashihara
    Hypertension Research, 2009, 32 : 194 - 200
  • [46] The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials
    Gerald Schulman
    Tomas Berl
    Gerald J. Beck
    Giuseppe Remuzzi
    Eberhard Ritz
    Miho Shimizu
    Yuko Shobu
    Mami Kikuchi
    BMC Nephrology, 17
  • [47] A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD
    Schulman, G
    Agarwal, R
    Acharya, M
    Berl, T
    Blumenthal, S
    Kopyt, N
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (04) : 565 - 577
  • [48] Oral adsorbent AST-120 ameliorates endothelial dysfunction independent of renal function in rats with subtotal nephrectomy
    Namikoshi, Tamehachi
    Tomita, Naruya
    Satoh, Minoru
    Sakuta, Takeo
    Kuwabara, Atsunori
    Kobayashi, Shinya
    Higuchi, Yuusuke
    Nishijima, Fuyuhiko
    Kashihara, Naoki
    HYPERTENSION RESEARCH, 2009, 32 (03) : 194 - 200
  • [49] Administration of oral charcoal adsorbent (AST-120) suppresses low-turnover bone progression in uraemic rats
    Iwasaki, Yoshiko
    Yamato, Hideyuki
    Nii-Kono, Tomoko
    Fujieda, Ayako
    Uchida, Motoyuki
    Hosokawa, Atsuko
    Motojima, Masaru
    Fukagawa, Masafumi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (10) : 2768 - 2774
  • [50] Effect of oral adsorbent (AST-120) on renal function, acquired renal cysts and aortic calcification in rats with adriamycin nephropathy
    Ishikawa, I
    Araya, M
    Hayama, T
    Sugano, M
    Yamato, H
    Ise, M
    NEPHRON, 2002, 92 (02): : 399 - 406
12345